A catalyst for meaningful advancement of surgical stapling
* A Spin-off of Galileo Surgical Innovation & Affiliated with Endoscape Surgical
pROLOGUE 1/3
After over three decades in clinical use the surgical staplers for internal use still suffer from problems that adversely impact safety and effectiveness.
pROLOGUE 2/3
Under the cover of unassailable benefit-risk profile the surgical stapler market has lost impetus to make clinically meaningful technological advancement.
pROLOGUE 3/3
With the surgical stapler market under a duopoly the only hope for revitalizing innovation drive may lie with a revamped regulatory oversight.
Measure Twice, Staple Once
Copernicus Surgical's Tissue Probe* line of products take the guesswork out of surgical stapling.
* granted a Breakthrough Device Designation by FDA in 2019
Copernicus Surgical aspires to be a catalyst for revitalizing innovation of the surgical stapling in supporting FDA's renewed regulatory oversight and Galileo Surgical Innovation's initiative to improve safety and effectiveness.